Metabolic
hGH Fragment 176-191
Also called HGH Frag 176-191, Somatropin fragment 176-191
per administration
Only animal or lab studies exist — no human study has set an amount.
Quick start
hGH Fragment 176-191 at a glance — the figures, plus how it's commonly run. Reference only, not medical advice.
- Typical dose
- 250–500 mcg per administration
- How often
- Every day
- Where
- Subcutaneous — abdomen, thigh, or upper arm Sites and rotation
- Time to steady level
- ~3 hours — about five half-lives
- Storage
- Dry vial kept cold and dark; a mixed vial in the fridge at 2–8 °C. Details
A research and community reference, not medical advice. Figures are descriptive, vary between sources, and are not a recommendation for use.
Work out your draw
These numbers are a starting point — change any of them.
Vial label
Copy this into your label printer.
Published research contexts for hGH Fragment 176-191 describe 250–500 mcg per administration. Descriptive only, not a recommendation.
Short in plasma; human pharmacokinetics for the bare fragment are thin.
The unmodified C-terminal fragment of growth hormone, distinct from the stabilised analog AOD-9604 listed separately. No human dose-ranging study fixes an injected amount or schedule; circulating figures are community-derived, so no schedule table is shown.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 3hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- hGH 176-191 fragment preclinical literatureLipolytic activity described in rodent and in-vitro work; the bare fragment's human amounts are community-derived, not trial-established.